Biosig technologies improves balance sheet, announces reduction in outstanding payables during q2 2024

Los angeles, ca 90025, july 25, 2024 (globe newswire) -- biosig technologies, inc. (otcqb: bsgm) or (“biosig” or "company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, is pleased to announce that it has successfully negotiated with multiple vendors an initial reduction in accounts payable of approximately $1.5 million during the second quarter of 2024 since new management has taken leadership.
BSGM Ratings Summary
BSGM Quant Ranking